What Happened?
Dallas, TX-based Peloton Therapeutics Promoted John Josey as Chief Executive Officer
About the Company
Peloton Therapeutics, Inc., is a clinical-stage biotechnology company that discovers and develops novel small molecule cancer therapies targeting unexploited molecular vulnerabilities. Peloton Therapeutics` lead programs are small molecule inhibitors targeting hypoxia inducible factor-2α (HIF-2α), a transcription factor implicated in the development and progression of kidney and other cancers.
About the Person
John Josey is Chief Executive Officer at Peloton Therapeutics. Previously, John held various senior HR leadership roles in the industry.
Info Source
News
Short Profile